Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)
Prospective Study of Bioresorbable Vascular Scaffold Treatment With Scoring Balloon Pre-dilatation in Patients With In-stent Restenosis
Sponsor: Abbott Medical Devices
This PHASE4 trial investigates Coronary In-stent Restenosis and is currently ongoing. Abbott Medical Devices leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Dec 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Mar 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Instituto de Investigación Sanitaria Hospital Universitario de la Princesa
- Spanish Society of Cardiology
- Terumo Medical Corporation
For direct contact, visit the study record on ClinicalTrials.gov .